Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

High-intensity Focused Ultrasound (HIFU) Therapy Market Worth USD 398,724 Thousand, by 2025| CAGR 21.8% | Allied Market Research

Allied Market Research
Posted on: 19 Jul 18
High-intensity Focused Ultrasound (HIFU) Therapy Market Worth USD 398,724 Thousand, by 2025| CAGR 21.8% | Allied Market Research

PR Newswire

PORTLAND, Oregon, July 19, 2018

PORTLAND, Oregon, July 19, 2018 /PRNewswire/ --

According to a new report published by Allied Market Research, titled, "High-intensity Focused Ultrasound (HIFU) Therapy Market by Application: Global Opportunity Analysis and Industry Forecast, 2018-2025", the market was valued at $81,000 thousand in 2017, and is projected to reach $398,724 thousand by 2025, growing at a CAGR of 21.8% from 2018 to 2025. Europe is anticipated to be the highest revenue contributor throughout the forecast period.

     (Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg )

HIFU is a minimally invasive technique used to treat diseases such as cancer with focused ultrasound waves, which destroy damaged tissues with precision and accuracy. The ultrasound waves are focused at a specific location or focal point. The targeted tissue at the focal point is destroyed, but tissue outside the focal point is unharmed.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4698

The HIFU therapy market is anticipated to grow considerably in the near future, owing to different factors such as increase in prevalence of chronic diseases such as cancer among the population, favorable regulatory scenario with respect to HIFU therapy, and rise in elderly population globally. However, limitations associated with HIFU therapy and dearth of skilled professionals are the key factors that are expected to impede the market growth. On the contrary, the emerging markets such as India and China are anticipated to provide lucrative growth opportunities to the market players during the forecast period.

By application, prostate cancer accounted for more than one-third share of the global HIFU therapy market in 2017. Furthermore, the aesthetics segment is anticipated to grow at the highest rate of 24.7% in the forecast period.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4698

Key Findings of the Study 

  • North America occupied a nearly one-third share of the global HIFU therapy market.
  • Aesthetics is anticipated to grow with the highest CAGR throughout the forecast period.
  • Europe is anticipated to nearly occupy a two-seventh market share of the global HIFU therapy market by 2023.
  • Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

Europe was the leading revenue contributor to the global market in 2017, owing to high adoption rate of HIFU devices. However, Asia-Pacific is expected to grow at the highest CAGR of 23.2% from 2018 to 2025, due to increase in disposable income; surge in research, development, & innovation activities; and rise in awareness towards HIFU therapy devices.

The report provides an extensive competitive analysis and profiles of the key market players such as Chongqing Haifu Medical Technology Co., Ltd., EDAP TMS S.A., SonaCare Medical, LLC., ILJIN Holdings Co., Ltd. (ALPINION MEDICAL SYSTEMS Co., Ltd.), Image Guided Therapy S.A., INSIGHTEC Ltd., Theraclion SA, Merz Pharmaceuticals GmbH (Ulthera, Inc.), Profound Medical Corp., and Shanghai A&S Technology Development Co., Ltd. The other players in the value chain (not included in the report) include Sonic Concepts, Inc., Mianyang Sonic Electronic Ltd., and FUS Instruments.

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas. 

Similar Reports:  

Ultrasound Devices Market for Pediatric Radiology - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ultrasound Devices Market - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

About Us 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com  

Web: https://www.alliedmarketresearch.com

SOURCE Allied Market Research

PR Newswire
www.prnewswire.com

Last updated on: 19/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.